Subscribers

German firm Syntellix opens first overseas facility in Singapore

The orthopaedic implant maker projects that overall investment will reach S$200 million by 2024, with a potential cumulative revenue of S$500 million by then

Singapore

SYNTELLIX, a German firm that pioneered the use of bioabsorbable bone implants, opened its first overseas production site in Singapore on Tuesday, amid expectations of strong growth in the medical technology industry in this region.

While initial investment in the facility falls within an undisclosed "single-digit" million dollars, Syntellix founder, CEO and executive chairman Utz Claassen projected overall investment to reach S$200 million by 2024, with a potential cumulative revenue of...

KEYWORDS IN THIS ARTICLE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes